Gregg Stanwood Ph.D.
Professor
Biosketch
I was trained as a developmental neurobiologist and neurotoxicologist but embrace and lead interdisciplinary studies related to human health. Cellular and molecular studies in my lab focus on the developmental basis of brain disorders. We examine the developmental influences of neurochemicals like dopamine and GLP-1 on brain structure and function. Dysregulation of these processes during neural development negatively affects brain structure and circuit function. We also engage in studies in human populations to study the effects of cognitive therapies on brain biomarkers and studying the effects of environmental chemicals like pesticides on neurological development and health disparities in rural populations, including farmworkers and their children. Our overall goals are to discover mechanisms that underlie risk and resiliency of brain health, discover new behavioral and drug therapies to treat brain disorders, and to establish new methods to improve the development and health of children. Prior to joining the faculty of Florida State University College of Medicine, I completed postdoctoral fellowships at the University of Pittsburgh and was on the faculty at Vanderbilt University.
Education
1992-1997: Ph.D. in Neuroscience, University of Pennsylvania, Philadelphia
1987-1991: B.A. in Biology and Psychology, summa cum laude, Temple University, Philadelphia
Service
Editorial Boards:
Editor in Chief, Neurotoxicology and Teratology 2024 – present
Associate Editor, Frontiers in Behavioural Neuroscience 2018 – present
Editorial Board, Scientific Reports 2023 – present
Editorial Board, Experimental Biology and Medicine 2016 – present
Associate Editor, Developmental Neuroscience 2013 – present
Section Editor, Neurotoxicology and Teratology 2017 – 2024
Reviewing Editor, Frontiers in Behavioural Neuroscience 2007 – 2018
Editorial Board, Neurotoxicology and Teratology 2011 – 2017
Editorial Board, Developmental Neuroscience 2011 – 2013
Peer Review:
Ad hoc Study Section Member, ZRG1 ICN-L 94 (Jun 2025)
Ad hoc Study Section Member, US-EPA (Nov 2023, Feb 2024)
Ad hoc Study Section Member, F01B – Learning and Memory, Language, Communication and Related Neurosciences Fellowships (Apr 2025)
Ad hoc Study Section Member, F02A – Behav. Neurosci. Fellowships (Jun 2022, Nov 2022, Jul 2023, Mar 2024, Jul 2024)
University of Minnesota’s Medical Discovery Team on Addiction Pilot Grant Program (June 2020)
Ad hoc Study Section Member, ZRG1 MDCN-G (AED) (March 2009)
Ad hoc Study Section Member, ZRG1 IFCN-L (96) M (AED) (July 2009)
Ad hoc Study Section Member, Developmental Brain Disorders (June 2009, October 2010, June 2011, June 2011, October 2011, June 2013, June 2015, Feb 2021, Jun 2021, Oct 2021)
Ad hoc Study Section Member, BRAINS (ZMH1 ERB-L) (June 2009, March 2010, March 2011)
Ad hoc Study Section Member, ZMH1 ERB-L (05) S (teleconference) (July 2011)
Ad hoc Study Section Member, MDCN J(04) (teleconference) (November 2012)
Ad hoc Study Section Member, ZMH1 ERB-L (02) S (teleconference) (November 2013)
Ad hoc Study Section Member, Neurogenesis and Cell Fate (February 2016)
The Netherlands Organisation for Health Research and Development (2012, 2013)
NWO Council for the Earth and Life Sciences (2013)
Oak Ridge Associated Universities, Ralph E. Powe Awards (2016)
Honors/Awards
1987-1991: Temple University Outstanding Achievement Scholar, summa cum laude
1993-1996: NSF Predoctoral Fellowship
1997-1998: NRSA Postdoctoral Training Grant Fellowship
1998-2000: PhRMA Foundation Pharmacology/Morphology Postdoctoral Fellowship
2010: American College of Neuropsychopharmacology Travel Fellow
2013: Vanderbilt Distinguished Faculty Award
2014: Mentor of the Year, Vanderbilt Neuroscience Graduate Group
2015: Patricia Rodier Mid-Career Award in Research and Mentoring, Teratology Society
2016: Elected President of the Developmental Neurotoxicology Society (DNTS)
2022: Outstanding Senior Faculty Researcher, FSU College of Medicine
2022: Outstanding Senior Faculty Educator, FSU College of Medicine
2023: Rising Star, Academy of Science, Engineering and Medicine of Florida (ASEMFL)
2025: Emerging Leader, National Academy of Medicine
Memberships
Society for Neuroscience (SfN), Developmental Neurotoxicology Society (DNTS), Society of Toxicology (SOT), American Society for Pharmacology and Experimental Therapeutics (ASPET)
Research Focus
The Stanwood lab's research interests are in the developmental basis of brain disorders and their effects on child health.
Publications
Ochegbu. C., Nguyen, T., Sood, I., Blankenship, K., He H., Stanwood, G.D., Vied, C., & Graham D.L. Prenatal fentanyl exposure affects social dominance and myelination patterns in the adult mouse brain. Neuropharmacology. 2025 Nov 1;278:110583. doi: 10.1016/j.neuropharm.2025.110583. Epub 2025 Jun 29. PMID: 40592379.
Rosado, J.I., Mesidor, J.K., Chege, S., Wang, Y., Torres, L., & Stanwood, G.D. Assessment of adverse childhood experiences in adolescents from a rural agricultural community: Associations with depressive symptoms and psychosocial problems. Neurotoxicol Teratol. 2024 Nov-Dec;106:107396. doi: 10.1016/j.ntt.2024.107396. Epub 2024 Sep 24. PMID: 39326686.
Jones, S.K., McCarthy D.M., Stanwood G.D., Schatschneider C., Bhide P.G. Learning and memory deficits produced by aspartame are heritable via the paternal lineage. Sci Rep. 2023 Aug 31;13(1):14326. doi: 10.1038/s41598-023-41213-2. PMID: 37652922; PMCID: PMC10471780.
Cheshure, A. Stanwood, G.D., Van Lith, T. & Pickett, S.M. Distinguishing difference through determining the mechanistic properties of mindfulness-based art therapy, Current Research in Behavioral Sciences, 2023, https://doi.org/10.1016/j.crbeha.2023.100106.
Jones S.K., McCarthy D.M., Vied C., Stanwood G.D., Schatschneider C., Bhide P.G. Transgenerational transmission of aspartame-induced anxiety and changes in glutamate-GABA signaling and gene expression in the amygdala. Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2213120119. doi: 10.1073/pnas.2213120119. Epub 2022 Dec 2. PMID: 36459641.
Lee, G., Graham, G.L. Noble, B.L, Trammell, T.S., McCarthy, D.M., Anderson, L.R., Rubinstein, M., Bhide, P.G., & Stanwood, G.D. Behavioral and neuroanatomical consequences of cell-type specific loss of dopamine D2 receptors in the mouse cerebral cortex, Front. Behav. Neurosci., 2022, Jan 13;15:815713. doi: 10.3389/fnbeh.2021.815713. PMID: 35095443.
Van Lith, T., Cheshure, A., Pickett, S.M., Stanwood, G.D., & Beerse, M. Mindfulness Based Art Therapy Protocol to Determine Efficacy in Reducing College Stress and Anxiety, BMC Psychol. 2021 Sep 3;9(1):134. doi: 10.1186/s40359-021-00634-2.
Graham, D.L., Madkour, H.S., Noble, B.L., Schatschneider, C. & Stanwood, G.D. Long-term functional alterations following prenatal GLP-1R activation Neurotoxicology and Teratology, 2021 Apr 20;87:106984. doi: 10.1016/j.ntt.2021.106984. PMID: 33864929.
Delva, N.C. & Stanwood, G.D. Dysregulation of brain dopamine systems in major depressive disorder. Experimental Biology and Medicine, 2021 Exp Biol Med (Maywood). 2021 Feb 16:1535370221991830. doi: 10.1177/1535370221991830. Online ahead of print. PMID: 33593109
Goldfarb, S.S, Stanwood, G.D., Flynn, H.A., & Graham, D.L. Developmental opioid exposures: neurobiological underpinnings, behavioral impacts and policy implications, Experimental Biology and Medicine, 2020 Oct 20:1535370219883601. doi: 10.1177/1535370219883601.
Trammell T.S., Henderson N.L., Madkour H.S., Stanwood G.D., Graham D.L. GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner. Neurol Sci. 2020 Nov 22. doi: 10.1007/s10072-020-04910-8. Epub ahead of print. PMID: 33222103.
Graham, D.L., Durai, H.H., Trammell, T.S., Mortlock, D.P., Galli, A. & Stanwood, G.D. A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain, Journal of Comparative Neurology, 2020 Mar 14. doi: 10.1002/cne.24905. [Epub ahead of print] PMID: 32170734.
Beerse, M.E., Van Lith, T., & Stanwood, G.D. Therapeutic Psychological and Biological Responses to Mindfulness-Based Art Therapy, Stress and Health 2020 Feb 19. doi: 10.1002/smi.2937. [Epub ahead of print] PMID: 32073202.
Anacker, A.M.J., Moran, J.T., Santarelli, S., Forsberg, C.G., Rogers, T.D., Stanwood, G.D., Hall, B.J., Delpire, E., Veenstra-VanderWeele, J., & Saxe, M.D. Enhanced social dominance and altered neuronal excitability in the prefrontal cortex of male KCC2b mutant mice. Autism Res. 2019 Apr 12. doi: 10.1002/aur.2098. PMID: 30977597.
Beerse, M.E., Van Lith, T. & Stanwood, G.D. Is There a Biofeedback Response to Art Therapy? A Technology-Assisted Approach for Reducing Anxiety and Stress in College Students, Sage Open 2019, https://doi.org/10.1177/2158244019854646.
Toki, S., Goleniewska, K., Reiss, S., Zhang, J., Bloodworth, M.H., Stier,M.T., Zhou, W., Newcomb, D.C., Ware, L.B., Stanwood, G.D., Galli, A., Boyd, K.L., Niswender, K.D., & Peebles Jr., R.S. Glucagon-like peptide 1 receptor agonist, liraglutide inhibits allergen-induced IL-33 release and reduced group 2 innate lymphoid cell (ILC2) cytokine production in vivo, J Allergy Clin Immunol. 2018 Jan 10. pii: S0091-6749(18)30027-7. PMID: 29331643.
Davis G.L., Stewart A., Stanwood G.D., Gowrishankar R., Hahn M.K., & Blakely R.D. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res. 2018 Jan 30;337:61-69. PMID: 28964912.
Zike, I.D., Chohan, M.O., Kopelman, J.M., Krasnow, E., Flicker, D., Nautiyal, K.M., Bubser, M. Kellendonk, C., Jones, C.K., Stanwood, G.D., Tanaka, K., Moore, H., Ahmari, S., & Veenstra-VanderWeele, J. OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior, Proc Natl Acad Sci U S A. 2017 May 30;114(22):5719-5724. PMID: 28507136.
Muller, C.L., Anacker, A.M., Rogers, T.D., Goeden, N., Keller, E.H., Forsberg, C.G., Kerr, T.M., Wender, C., Anderson, G.M., Stanwood, G.D., Blakely, R.D., Bonnin, A., Veenstra-VanderWeele J. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment, Neuropsychopharmacology. 2017 Jan;42(2):427-436. doi: 10.1038/npp.2016.166. Epub 2016 Aug 23. PMID: 27550733.
Reddy I.A., Pino J.A., Weikop P., Osses N., Sørensen G., Bering T., Valle C., Bluett R.J., Erreger K., Wortwein G., Reyes J.G., Graham D., Stanwood G.D., Hackett T.A., Patel S., Fink-Jensen A., Torres G.E. Galli A. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Transl Psychiatry. 2016 May 17;6:e809. doi: 10.1038/tp.2016.86
Martin, M.M., Graham, D.L., McCarthy, D.M., Bhide, P.G. & Stanwood, G.D. Cocaine-induced neurodevelopmental deficits and underlying mechanisms, Birth Defects Res C Embryo Today, 2016, Jun; 108:147-73.
Frederick, A.L., Yano, H., Triflieff, P., Vishwasrao, H.D., Biezonski, D., Mészáros, J., Sibley, D.R., Kellendonk, C., Sontag, K.C., Graham, D.L., Colbran, R.J., Stanwood, G.D. & Javitch, J. Evidence against dopamine D1/D2 receptor heteromers, Molecular Psychiatry, 2015, Jan 6. doi: 10.1038/mp.2014.166. (Stanwood and Javitch are co-senior authors).
Sørensen, G., Reddy, I., Weikop, P., Graham, D.L., Stanwood, G.D., Wortwein, G., Galli, A. & Fink-Jensen, A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice, Physiology and Behavior, 2015, 149:262-268. doi: 10.1016/j.physbeh.2015.06.013.
Graham, D.L., Buendia, M.A., Durai, H.H, Akel, M.J., Chapman, M.A. & Stanwood, G.D. Cerebral cortical deletion of Gaq (Gnaq) alters behavior, Synapse, 2015 Sep;69(9):434-45. PMID: 25963901.
Samuelson, L., Scherer, R., VanSaun, M., Fan, K-H., Dozier, E., Carter, K., Shyr, Y., Aschner, M. Stanwood, G., Bornhop, D., Matrisian, L. & McIntyre, O. New tools for the preclinical quantitative assessment of peripheral neurotoxicity and prodrug delivery, Neurotoxicology. 2015 Feb 27;47:88-98. doi: 10.1016/j.neuro.2015.02.005.
Graham, D.L., Durai, H.H., Garden, J.D., Cohen, E., Echevarria, F.D. & Stanwood, G.D. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex, 2015, ACS Chemical Neuroscience, 6(2):297-305. doi: 10.1021/cn500235m. PMID: 25393953.
Mergy, M.A., Gowrishankar, R., Gresch, P.J., Gantz, S.C., Williams, J.T., Davis, G.L., Wheeler, C.A., Stanwood, G.D., Hahn, M.K. & Blakely, R.D. The rare dopamine transporter variant Val559 disrupts dopamine neuronal function, changes behavior and alters in vivo responses to psychostimulants, PNAS, 2014, Nov 4;111(44):E4779-88. doi: 10.1073/pnas.1417294111.
Coke-Murphy, C., Buendia, M.A., Saborido, T.P. & Stanwood, G.D. Simple shelter-style environmental enrichment alters behavior in mice, Translational Neuroscience, 2014, 5: 185-96.
Kocalis, H.E., Hagan, S.L., George, L., Turney, M.K., Siuta, M.A., Laryea, G.N., Morris, L.C., Muglia, L.J., Printz, R.L., Stanwood, G.D. & Niswender, K.D. Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis. Molecular Metabolism, 2014, 3:394-407.
Graham, D.L, Erreger K., Galli A. & Stanwood, G.D.. GLP-1 analog attenuates cocaine reward, Molecular Psychiatry, 2013 Sep;18(9):961-2. doi: 10.1038/mp.2012.141. Epub 2012 Oct 23. PMID: 23089631.
Ross, E.J., Graham, D.L., Money, K.M. & Stanwood, G.D. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn, Neuropsychopharmacology Reviews, 2014, Jun 18. doi: 10.1038/npp.2014.147. [Epub ahead of print].
Money, K.M. & Stanwood, G.D. Developmental origins of brain disorders: roles for dopamine, Frontiers in Cellular Neuroscience, 2013 Dec 19; 7:260. PMID: 24391541.
Reddy, I.A., Stanwood, G.D. & Galli A. Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward, Neurochemistry International, 2013 Oct 16. pii: S0197-0186(13)00259-3. doi: 10.1016/j.neuint.2013.10.003., PMID:24140429.
Kocalis H.E., Turney M.K., Printz R.L., Laryea G.N., Muglia L.J., Davies S.S., Stanwood, G.D., McGuinness O.P. & Niswender K.D. Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity. PLoS One. 2012, 7(8):e42981, Epub 2012 Aug 20, PMID: 22916190.
Killinger, C.E., Robinson, S. & Stanwood, G.D. Subtle biobehavioral effects produced by paternal cocaine exposure, Synapse, 2012, 66:902-8, PMID:22807092.
Frederick, A.L., Saborido, T.P. & Stanwood, G.D. Neurobehavioral phenotyping of G?q knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair, Frontiers in Behavioral Neuroscience, 2012, 6:29. Epub 2012 Jun 19, PMID:22723772.
Jackson, C.R., Ruan, G.X., Aseem, F., Abey, J., Gamble, K., Stanwood, G., Palmiter, R., Iuvone, P.M. & McMahon, D. Retinal dopamine mediates multiple dimensions of light-adapted vision, Journal of Neuroscience, 2012, 32:9359-9368, PMID:22764243.
McLaughlin, B., Buendia, M.A., Saborido, T.P., Kleman, A.M. & Stanwood, G.D. C-terminus of heat shock cognate 70 Interacting Protein (CHIP) haploinsufficiency produces specific behavioral impairments, PLoS ONE, 7(5):e36340. Epub 2012 May 11, PMID: 22606257.
Carpenter, A.C., Saborido, T.P. & Stanwood, G.D. Development of behavioral responses in dopamine transporter deficient mice, Developmental Neuroscience, 2012, 34(2-3):250-7, PMID: 22572477.
Swant, J., Chirwa, S., Stanwood, G. & Khoshbouei, H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus, PLoS ONE, 5: e11382, 2010, PMID: 20614033.
Siuta, M., Robertson, S., Kocalis, H., Saunders, C., Gresch, P., Khatri, V., Shiota, C., Kennedy, J.P., Lindsley, C., Daws, L., Polley, D., Veenstra-Vanderweele, J., Stanwood, G.D., Magnuson, M., Niswender, K. & Galli, A. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal Rictor null mice, PLoS Biology, 8:e1000393, 2010, PMID: 20543991.
Neely, M.D., Stanwood, G.D. & Deutch, A.Y. Combination of DiOlistic labeling with retrograde tract tracing and immunohistochemistry, Journal of Neuroscience Methods, 184: 332-6, 2009, PMID: 19712695.
Stanwood, G.D., Leitch, D.B., Savchenko V., Wu, J., Fitsanakis, V.A., Anderson, D.J., Stankowski, J.N., Aschner, M. & McLaughlin, B. Chronic manganese exposure in mice is neurotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia, 110: 378-89, Journal of Neurochemistry, 2009, PMID: 19457100.
Thompson, B.L., Levitt, P. & Stanwood, G.D. The effects of prenatal exposure to drugs on brain development and function: implications for policy and education, Nature Neuroscience Reviews, 10:303-12, 2009. PMID: 19277053 Frederick, A.L. & Stanwood, G.D. Drugs, biogenic amine targets and the developing brain, Developmental Neuroscience, 31: 7-22, 2009. PMID: 19372683
Thompson, B.L. & Stanwood, G.D. Pleiotropic effects of neurotransmission during development: modulators of modularity, Journal of Autism and Developmental Disabilities, 39: 260-268, 2009. PMID: 18648918
Stanwood, G.D. & Levitt, P. The effects of monoamines on the developing nervous system, Handbook of Developmental Cognitive Neuroscience 2nd ed., edited by Nelson, C.A. & Luciana, M., MIT Press, 83-94, 2008.
Overton, D.A., Stanwood, G.D., Patel, B.N., Pragada, S.R. & Gordon, M.K. Measurement of the lowest dosage of phenobarbital that can produce drug discrimination in rats, Psychopharmacology, 203: 213-8, 2008, PMID: 19082292.
Couppis, M.H., Kennedy, C.H. & Stanwood, G.D. Alterations in the mesocorticolimbic dopamine system in mouse strains that differ in aggressive behavior, Synapse, 62: 714-725, 2008, PMID: 18651644.
Parlaman, J.P., Thompson, B.L., Levitt, P. & Stanwood, G.D. Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit, European Journal of Pharmacology, 563: 124-29, 2007, PMID: 17383635.
Stanwood, G.D. & Levitt, P. Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine, Synapse, 61: 259-62, 2007, PMID: 17230552.
Stanwood, G.D. & Levitt, P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution, Journal of Neuroscience, 27: 152-7, 2007, PMID: 17202482.
Stanwood, G.D., Parlaman, J.P. & Levitt, P. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signaling (Rgs) transcripts, European Journal of Neuroscience, 24:806-818, 2006, PMID:16930410.
Thompson, B.L., Levitt, P. & Stanwood, G.D. Prenatal cocaine specifically alters spontaneous alternation behavior, Behavioural Brain Research, 164: 107-16, 2005, PMID: 16054247.
Stanwood, G.D., Parlaman, J.P. & Levitt, P. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice, Journal of Comparative Neurology, 487: 270-82, 2005, PMID: 15892099.
Stanwood, G.D. & Levitt, P. Repeated intravenous cocaine exposure produces long-lasting behavioral sensitization in pregnant adults, but behavioral tolerance in their offspring, Neuroscience, 122: 579-583, 2003, PMID: 14622900.
I was trained as a developmental neurobiologist and neurotoxicologist but embrace and lead interdisciplinary studies related to human health. Cellular and molecular studies in my lab focus on the developmental basis of brain disorders. We examine the developmental influences of neurochemicals like dopamine and GLP-1 on brain structure and function. Dysregulation of these processes during neural development negatively affects brain structure and circuit function. We also engage in studies in human populations to study the effects of cognitive therapies on brain biomarkers and studying the effects of environmental chemicals like pesticides on neurological development and health disparities in rural populations, including farmworkers and their children. Our overall goals are to discover mechanisms that underlie risk and resiliency of brain health, discover new behavioral and drug therapies to treat brain disorders, and to establish new methods to improve the development and health of children. Prior to joining the faculty of Florida State University College of Medicine, I completed postdoctoral fellowships at the University of Pittsburgh and was on the faculty at Vanderbilt University.
1992-1997: Ph.D. in Neuroscience, University of Pennsylvania, Philadelphia
1987-1991: B.A. in Biology and Psychology, summa cum laude, Temple University, Philadelphia
Editorial Boards:
Editor in Chief, Neurotoxicology and Teratology 2024 – present
Associate Editor, Frontiers in Behavioural Neuroscience 2018 – present
Editorial Board, Scientific Reports 2023 – present
Editorial Board, Experimental Biology and Medicine 2016 – present
Associate Editor, Developmental Neuroscience 2013 – present
Section Editor, Neurotoxicology and Teratology 2017 – 2024
Reviewing Editor, Frontiers in Behavioural Neuroscience 2007 – 2018
Editorial Board, Neurotoxicology and Teratology 2011 – 2017
Editorial Board, Developmental Neuroscience 2011 – 2013
Peer Review:
Ad hoc Study Section Member, ZRG1 ICN-L 94 (Jun 2025)
Ad hoc Study Section Member, US-EPA (Nov 2023, Feb 2024)
Ad hoc Study Section Member, F01B – Learning and Memory, Language, Communication and Related Neurosciences Fellowships (Apr 2025)
Ad hoc Study Section Member, F02A – Behav. Neurosci. Fellowships (Jun 2022, Nov 2022, Jul 2023, Mar 2024, Jul 2024)
University of Minnesota’s Medical Discovery Team on Addiction Pilot Grant Program (June 2020)
Ad hoc Study Section Member, ZRG1 MDCN-G (AED) (March 2009)
Ad hoc Study Section Member, ZRG1 IFCN-L (96) M (AED) (July 2009)
Ad hoc Study Section Member, Developmental Brain Disorders (June 2009, October 2010, June 2011, June 2011, October 2011, June 2013, June 2015, Feb 2021, Jun 2021, Oct 2021)
Ad hoc Study Section Member, BRAINS (ZMH1 ERB-L) (June 2009, March 2010, March 2011)
Ad hoc Study Section Member, ZMH1 ERB-L (05) S (teleconference) (July 2011)
Ad hoc Study Section Member, MDCN J(04) (teleconference) (November 2012)
Ad hoc Study Section Member, ZMH1 ERB-L (02) S (teleconference) (November 2013)
Ad hoc Study Section Member, Neurogenesis and Cell Fate (February 2016)
The Netherlands Organisation for Health Research and Development (2012, 2013)
NWO Council for the Earth and Life Sciences (2013)
Oak Ridge Associated Universities, Ralph E. Powe Awards (2016)
1987-1991: Temple University Outstanding Achievement Scholar, summa cum laude
1993-1996: NSF Predoctoral Fellowship
1997-1998: NRSA Postdoctoral Training Grant Fellowship
1998-2000: PhRMA Foundation Pharmacology/Morphology Postdoctoral Fellowship
2010: American College of Neuropsychopharmacology Travel Fellow
2013: Vanderbilt Distinguished Faculty Award
2014: Mentor of the Year, Vanderbilt Neuroscience Graduate Group
2015: Patricia Rodier Mid-Career Award in Research and Mentoring, Teratology Society
2016: Elected President of the Developmental Neurotoxicology Society (DNTS)
2022: Outstanding Senior Faculty Researcher, FSU College of Medicine
2022: Outstanding Senior Faculty Educator, FSU College of Medicine
2023: Rising Star, Academy of Science, Engineering and Medicine of Florida (ASEMFL)
2025: Emerging Leader, National Academy of Medicine
Society for Neuroscience (SfN), Developmental Neurotoxicology Society (DNTS), Society of Toxicology (SOT), American Society for Pharmacology and Experimental Therapeutics (ASPET)
The Stanwood lab's research interests are in the developmental basis of brain disorders and their effects on child health.
Ochegbu. C., Nguyen, T., Sood, I., Blankenship, K., He H., Stanwood, G.D., Vied, C., & Graham D.L. Prenatal fentanyl exposure affects social dominance and myelination patterns in the adult mouse brain. Neuropharmacology. 2025 Nov 1;278:110583. doi: 10.1016/j.neuropharm.2025.110583. Epub 2025 Jun 29. PMID: 40592379.
Rosado, J.I., Mesidor, J.K., Chege, S., Wang, Y., Torres, L., & Stanwood, G.D. Assessment of adverse childhood experiences in adolescents from a rural agricultural community: Associations with depressive symptoms and psychosocial problems. Neurotoxicol Teratol. 2024 Nov-Dec;106:107396. doi: 10.1016/j.ntt.2024.107396. Epub 2024 Sep 24. PMID: 39326686.
Jones, S.K., McCarthy D.M., Stanwood G.D., Schatschneider C., Bhide P.G. Learning and memory deficits produced by aspartame are heritable via the paternal lineage. Sci Rep. 2023 Aug 31;13(1):14326. doi: 10.1038/s41598-023-41213-2. PMID: 37652922; PMCID: PMC10471780.
Cheshure, A. Stanwood, G.D., Van Lith, T. & Pickett, S.M. Distinguishing difference through determining the mechanistic properties of mindfulness-based art therapy, Current Research in Behavioral Sciences, 2023, https://doi.org/10.1016/j.crbeha.2023.100106.
Jones S.K., McCarthy D.M., Vied C., Stanwood G.D., Schatschneider C., Bhide P.G. Transgenerational transmission of aspartame-induced anxiety and changes in glutamate-GABA signaling and gene expression in the amygdala. Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2213120119. doi: 10.1073/pnas.2213120119. Epub 2022 Dec 2. PMID: 36459641.
Lee, G., Graham, G.L. Noble, B.L, Trammell, T.S., McCarthy, D.M., Anderson, L.R., Rubinstein, M., Bhide, P.G., & Stanwood, G.D. Behavioral and neuroanatomical consequences of cell-type specific loss of dopamine D2 receptors in the mouse cerebral cortex, Front. Behav. Neurosci., 2022, Jan 13;15:815713. doi: 10.3389/fnbeh.2021.815713. PMID: 35095443.
Van Lith, T., Cheshure, A., Pickett, S.M., Stanwood, G.D., & Beerse, M. Mindfulness Based Art Therapy Protocol to Determine Efficacy in Reducing College Stress and Anxiety, BMC Psychol. 2021 Sep 3;9(1):134. doi: 10.1186/s40359-021-00634-2.
Graham, D.L., Madkour, H.S., Noble, B.L., Schatschneider, C. & Stanwood, G.D. Long-term functional alterations following prenatal GLP-1R activation Neurotoxicology and Teratology, 2021 Apr 20;87:106984. doi: 10.1016/j.ntt.2021.106984. PMID: 33864929.
Delva, N.C. & Stanwood, G.D. Dysregulation of brain dopamine systems in major depressive disorder. Experimental Biology and Medicine, 2021 Exp Biol Med (Maywood). 2021 Feb 16:1535370221991830. doi: 10.1177/1535370221991830. Online ahead of print. PMID: 33593109
Goldfarb, S.S, Stanwood, G.D., Flynn, H.A., & Graham, D.L. Developmental opioid exposures: neurobiological underpinnings, behavioral impacts and policy implications, Experimental Biology and Medicine, 2020 Oct 20:1535370219883601. doi: 10.1177/1535370219883601.
Trammell T.S., Henderson N.L., Madkour H.S., Stanwood G.D., Graham D.L. GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner. Neurol Sci. 2020 Nov 22. doi: 10.1007/s10072-020-04910-8. Epub ahead of print. PMID: 33222103.
Graham, D.L., Durai, H.H., Trammell, T.S., Mortlock, D.P., Galli, A. & Stanwood, G.D. A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain, Journal of Comparative Neurology, 2020 Mar 14. doi: 10.1002/cne.24905. [Epub ahead of print] PMID: 32170734.
Beerse, M.E., Van Lith, T., & Stanwood, G.D. Therapeutic Psychological and Biological Responses to Mindfulness-Based Art Therapy, Stress and Health 2020 Feb 19. doi: 10.1002/smi.2937. [Epub ahead of print] PMID: 32073202.
Anacker, A.M.J., Moran, J.T., Santarelli, S., Forsberg, C.G., Rogers, T.D., Stanwood, G.D., Hall, B.J., Delpire, E., Veenstra-VanderWeele, J., & Saxe, M.D. Enhanced social dominance and altered neuronal excitability in the prefrontal cortex of male KCC2b mutant mice. Autism Res. 2019 Apr 12. doi: 10.1002/aur.2098. PMID: 30977597.
Beerse, M.E., Van Lith, T. & Stanwood, G.D. Is There a Biofeedback Response to Art Therapy? A Technology-Assisted Approach for Reducing Anxiety and Stress in College Students, Sage Open 2019, https://doi.org/10.1177/2158244019854646.
Toki, S., Goleniewska, K., Reiss, S., Zhang, J., Bloodworth, M.H., Stier,M.T., Zhou, W., Newcomb, D.C., Ware, L.B., Stanwood, G.D., Galli, A., Boyd, K.L., Niswender, K.D., & Peebles Jr., R.S. Glucagon-like peptide 1 receptor agonist, liraglutide inhibits allergen-induced IL-33 release and reduced group 2 innate lymphoid cell (ILC2) cytokine production in vivo, J Allergy Clin Immunol. 2018 Jan 10. pii: S0091-6749(18)30027-7. PMID: 29331643.
Davis G.L., Stewart A., Stanwood G.D., Gowrishankar R., Hahn M.K., & Blakely R.D. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res. 2018 Jan 30;337:61-69. PMID: 28964912.
Zike, I.D., Chohan, M.O., Kopelman, J.M., Krasnow, E., Flicker, D., Nautiyal, K.M., Bubser, M. Kellendonk, C., Jones, C.K., Stanwood, G.D., Tanaka, K., Moore, H., Ahmari, S., & Veenstra-VanderWeele, J. OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior, Proc Natl Acad Sci U S A. 2017 May 30;114(22):5719-5724. PMID: 28507136.
Muller, C.L., Anacker, A.M., Rogers, T.D., Goeden, N., Keller, E.H., Forsberg, C.G., Kerr, T.M., Wender, C., Anderson, G.M., Stanwood, G.D., Blakely, R.D., Bonnin, A., Veenstra-VanderWeele J. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment, Neuropsychopharmacology. 2017 Jan;42(2):427-436. doi: 10.1038/npp.2016.166. Epub 2016 Aug 23. PMID: 27550733.
Reddy I.A., Pino J.A., Weikop P., Osses N., Sørensen G., Bering T., Valle C., Bluett R.J., Erreger K., Wortwein G., Reyes J.G., Graham D., Stanwood G.D., Hackett T.A., Patel S., Fink-Jensen A., Torres G.E. Galli A. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Transl Psychiatry. 2016 May 17;6:e809. doi: 10.1038/tp.2016.86
Martin, M.M., Graham, D.L., McCarthy, D.M., Bhide, P.G. & Stanwood, G.D. Cocaine-induced neurodevelopmental deficits and underlying mechanisms, Birth Defects Res C Embryo Today, 2016, Jun; 108:147-73.
Frederick, A.L., Yano, H., Triflieff, P., Vishwasrao, H.D., Biezonski, D., Mészáros, J., Sibley, D.R., Kellendonk, C., Sontag, K.C., Graham, D.L., Colbran, R.J., Stanwood, G.D. & Javitch, J. Evidence against dopamine D1/D2 receptor heteromers, Molecular Psychiatry, 2015, Jan 6. doi: 10.1038/mp.2014.166. (Stanwood and Javitch are co-senior authors).
Sørensen, G., Reddy, I., Weikop, P., Graham, D.L., Stanwood, G.D., Wortwein, G., Galli, A. & Fink-Jensen, A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice, Physiology and Behavior, 2015, 149:262-268. doi: 10.1016/j.physbeh.2015.06.013.
Graham, D.L., Buendia, M.A., Durai, H.H, Akel, M.J., Chapman, M.A. & Stanwood, G.D. Cerebral cortical deletion of Gaq (Gnaq) alters behavior, Synapse, 2015 Sep;69(9):434-45. PMID: 25963901.
Samuelson, L., Scherer, R., VanSaun, M., Fan, K-H., Dozier, E., Carter, K., Shyr, Y., Aschner, M. Stanwood, G., Bornhop, D., Matrisian, L. & McIntyre, O. New tools for the preclinical quantitative assessment of peripheral neurotoxicity and prodrug delivery, Neurotoxicology. 2015 Feb 27;47:88-98. doi: 10.1016/j.neuro.2015.02.005.
Graham, D.L., Durai, H.H., Garden, J.D., Cohen, E., Echevarria, F.D. & Stanwood, G.D. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex, 2015, ACS Chemical Neuroscience, 6(2):297-305. doi: 10.1021/cn500235m. PMID: 25393953.
Mergy, M.A., Gowrishankar, R., Gresch, P.J., Gantz, S.C., Williams, J.T., Davis, G.L., Wheeler, C.A., Stanwood, G.D., Hahn, M.K. & Blakely, R.D. The rare dopamine transporter variant Val559 disrupts dopamine neuronal function, changes behavior and alters in vivo responses to psychostimulants, PNAS, 2014, Nov 4;111(44):E4779-88. doi: 10.1073/pnas.1417294111.
Coke-Murphy, C., Buendia, M.A., Saborido, T.P. & Stanwood, G.D. Simple shelter-style environmental enrichment alters behavior in mice, Translational Neuroscience, 2014, 5: 185-96.
Kocalis, H.E., Hagan, S.L., George, L., Turney, M.K., Siuta, M.A., Laryea, G.N., Morris, L.C., Muglia, L.J., Printz, R.L., Stanwood, G.D. & Niswender, K.D. Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis. Molecular Metabolism, 2014, 3:394-407.
Graham, D.L, Erreger K., Galli A. & Stanwood, G.D.. GLP-1 analog attenuates cocaine reward, Molecular Psychiatry, 2013 Sep;18(9):961-2. doi: 10.1038/mp.2012.141. Epub 2012 Oct 23. PMID: 23089631.
Ross, E.J., Graham, D.L., Money, K.M. & Stanwood, G.D. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn, Neuropsychopharmacology Reviews, 2014, Jun 18. doi: 10.1038/npp.2014.147. [Epub ahead of print].
Money, K.M. & Stanwood, G.D. Developmental origins of brain disorders: roles for dopamine, Frontiers in Cellular Neuroscience, 2013 Dec 19; 7:260. PMID: 24391541.
Reddy, I.A., Stanwood, G.D. & Galli A. Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward, Neurochemistry International, 2013 Oct 16. pii: S0197-0186(13)00259-3. doi: 10.1016/j.neuint.2013.10.003., PMID:24140429.
Kocalis H.E., Turney M.K., Printz R.L., Laryea G.N., Muglia L.J., Davies S.S., Stanwood, G.D., McGuinness O.P. & Niswender K.D. Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity. PLoS One. 2012, 7(8):e42981, Epub 2012 Aug 20, PMID: 22916190.
Killinger, C.E., Robinson, S. & Stanwood, G.D. Subtle biobehavioral effects produced by paternal cocaine exposure, Synapse, 2012, 66:902-8, PMID:22807092.
Frederick, A.L., Saborido, T.P. & Stanwood, G.D. Neurobehavioral phenotyping of G?q knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair, Frontiers in Behavioral Neuroscience, 2012, 6:29. Epub 2012 Jun 19, PMID:22723772.
Jackson, C.R., Ruan, G.X., Aseem, F., Abey, J., Gamble, K., Stanwood, G., Palmiter, R., Iuvone, P.M. & McMahon, D. Retinal dopamine mediates multiple dimensions of light-adapted vision, Journal of Neuroscience, 2012, 32:9359-9368, PMID:22764243.
McLaughlin, B., Buendia, M.A., Saborido, T.P., Kleman, A.M. & Stanwood, G.D. C-terminus of heat shock cognate 70 Interacting Protein (CHIP) haploinsufficiency produces specific behavioral impairments, PLoS ONE, 7(5):e36340. Epub 2012 May 11, PMID: 22606257.
Carpenter, A.C., Saborido, T.P. & Stanwood, G.D. Development of behavioral responses in dopamine transporter deficient mice, Developmental Neuroscience, 2012, 34(2-3):250-7, PMID: 22572477.
Swant, J., Chirwa, S., Stanwood, G. & Khoshbouei, H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus, PLoS ONE, 5: e11382, 2010, PMID: 20614033.
Siuta, M., Robertson, S., Kocalis, H., Saunders, C., Gresch, P., Khatri, V., Shiota, C., Kennedy, J.P., Lindsley, C., Daws, L., Polley, D., Veenstra-Vanderweele, J., Stanwood, G.D., Magnuson, M., Niswender, K. & Galli, A. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal Rictor null mice, PLoS Biology, 8:e1000393, 2010, PMID: 20543991.
Neely, M.D., Stanwood, G.D. & Deutch, A.Y. Combination of DiOlistic labeling with retrograde tract tracing and immunohistochemistry, Journal of Neuroscience Methods, 184: 332-6, 2009, PMID: 19712695.
Stanwood, G.D., Leitch, D.B., Savchenko V., Wu, J., Fitsanakis, V.A., Anderson, D.J., Stankowski, J.N., Aschner, M. & McLaughlin, B. Chronic manganese exposure in mice is neurotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia, 110: 378-89, Journal of Neurochemistry, 2009, PMID: 19457100.
Thompson, B.L., Levitt, P. & Stanwood, G.D. The effects of prenatal exposure to drugs on brain development and function: implications for policy and education, Nature Neuroscience Reviews, 10:303-12, 2009. PMID: 19277053 Frederick, A.L. & Stanwood, G.D. Drugs, biogenic amine targets and the developing brain, Developmental Neuroscience, 31: 7-22, 2009. PMID: 19372683
Thompson, B.L. & Stanwood, G.D. Pleiotropic effects of neurotransmission during development: modulators of modularity, Journal of Autism and Developmental Disabilities, 39: 260-268, 2009. PMID: 18648918
Stanwood, G.D. & Levitt, P. The effects of monoamines on the developing nervous system, Handbook of Developmental Cognitive Neuroscience 2nd ed., edited by Nelson, C.A. & Luciana, M., MIT Press, 83-94, 2008.
Overton, D.A., Stanwood, G.D., Patel, B.N., Pragada, S.R. & Gordon, M.K. Measurement of the lowest dosage of phenobarbital that can produce drug discrimination in rats, Psychopharmacology, 203: 213-8, 2008, PMID: 19082292.
Couppis, M.H., Kennedy, C.H. & Stanwood, G.D. Alterations in the mesocorticolimbic dopamine system in mouse strains that differ in aggressive behavior, Synapse, 62: 714-725, 2008, PMID: 18651644.
Parlaman, J.P., Thompson, B.L., Levitt, P. & Stanwood, G.D. Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit, European Journal of Pharmacology, 563: 124-29, 2007, PMID: 17383635.
Stanwood, G.D. & Levitt, P. Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine, Synapse, 61: 259-62, 2007, PMID: 17230552.
Stanwood, G.D. & Levitt, P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution, Journal of Neuroscience, 27: 152-7, 2007, PMID: 17202482.
Stanwood, G.D., Parlaman, J.P. & Levitt, P. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signaling (Rgs) transcripts, European Journal of Neuroscience, 24:806-818, 2006, PMID:16930410.
Thompson, B.L., Levitt, P. & Stanwood, G.D. Prenatal cocaine specifically alters spontaneous alternation behavior, Behavioural Brain Research, 164: 107-16, 2005, PMID: 16054247.
Stanwood, G.D., Parlaman, J.P. & Levitt, P. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice, Journal of Comparative Neurology, 487: 270-82, 2005, PMID: 15892099.
Stanwood, G.D. & Levitt, P. Repeated intravenous cocaine exposure produces long-lasting behavioral sensitization in pregnant adults, but behavioral tolerance in their offspring, Neuroscience, 122: 579-583, 2003, PMID: 14622900.